In subcutaneous tumors of TTN-MUT and DLL4-OE 4T1 mice, therapy with the MCT4 inhibitor VB-124 decreased tumor-infiltrated MDSCs (Fig. 5o-s). This evidence concerns the gene DLL4 and neoplasm.